CVA Family Office’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $909K | Sell |
10,424
-486
| -4% | -$42.4K | 0.13% | 106 |
|
|
2025
Q1 | $980K | Buy |
10,910
+704
| +7% | +$63.3K | 0.15% | 100 |
|
|
2024
Q4 | $815K | Buy |
10,206
+2,218
| +28% | +$177K | 0.13% | 109 |
|
|
2024
Q3 | $719K | Sell |
7,988
-644
| -7% | -$58K | 0.12% | 119 |
|
|
2024
Q2 | $679K | Sell |
8,632
-389
| -4% | -$30.6K | 0.12% | 114 |
|
|
2024
Q1 | $786K | Buy |
9,021
+6
| +0.1% | +$523 | 0.14% | 104 |
|
|
2023
Q4 | $743K | Sell |
9,015
-705
| -7% | -$58.1K | 0.14% | 102 |
|
|
2023
Q3 | $762K | Sell |
9,720
-233
| -2% | -$18.3K | 0.17% | 93 |
|
|
2023
Q2 | $877K | Buy |
9,953
+852
| +9% | +$75.1K | 0.18% | 85 |
|
|
2023
Q1 | $734K | Buy |
9,101
+2,731
| +43% | +$220K | 0.16% | 96 |
|
|
2022
Q4 | $495K | Sell |
6,370
-2,320
| -27% | -$180K | 0.12% | 116 |
|
|
2022
Q3 | $702K | Buy |
8,690
+3,636
| +72% | +$294K | 0.19% | 87 |
|
|
2022
Q2 | $454K | Buy |
5,054
+1,175
| +30% | +$106K | 0.12% | 103 |
|
|
2022
Q1 | $430K | Buy |
3,879
+1,407
| +57% | +$156K | 0.1% | 111 |
|
|
2021
Q4 | $256K | Buy |
2,472
+1,039
| +73% | +$108K | 0.06% | 151 |
|
|
2021
Q3 | $149K | Sell |
1,433
-2,950
| -67% | -$307K | 0.11% | 99 |
|
|
2021
Q2 | $544K | Buy |
4,383
+1,620
| +59% | +$201K | 0.15% | 88 |
|
|
2021
Q1 | $326K | Buy |
2,763
+1,130
| +69% | +$133K | 0.12% | 100 |
|
|
2020
Q4 | $191K | Buy |
1,633
+200
| +14% | +$23.4K | 0.12% | 97 |
|
|
2020
Q3 | $149K | Buy |
1,433
+212
| +17% | +$22K | 0.11% | 99 |
|
|
2020
Q2 | $112K | Buy |
1,221
+608
| +99% | +$55.8K | 0.09% | 106 |
|
|
2020
Q1 | $55K | Buy |
+613
| New | +$55K | 0.06% | 135 |
|